![Sylvia Cheung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sylvia Cheung
Directeur Financier/CFO chez
OCULIS HOLDING AG
Fortune : 947 121 $ au 31/08/2026
Profil
Sylvia Cheung is currently Chief Financial Officer at Oculis Holding AG since 2020.
Formerly, Ms. Cheung was Chief Financial Officer & Treasurer at Anika Therapeutics, Inc. in 2020, Principal at Transkaryotic Therapies, Inc. from 2000 to 2005, Senior Associate at PricewaterhouseCoopers LLP from 1995 to 2000, and General Manager at Anika Therapeutics Srl.
Ms. Cheung earned an MBA from Boston University and completed undergraduate studies at the University of Massachusetts.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCULIS HOLDING AG 0,11 % | 31/12/2025 | 77 316 ( 0,11 % ) | 947 121 $ | 31/08/2026 |
Postes actifs de Sylvia Cheung
| Sociétés | Poste | Début |
|---|---|---|
| OCULIS HOLDING AG | Directeur Financier/CFO | 01/09/2020 |
Anciens postes connus de Sylvia Cheung
| Sociétés | Poste | Fin |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Directeur Financier/CFO | 10/08/2020 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Corporate Officer/Principal | - |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Corporate Officer/Principal | 01/01/2000 |
Anika Therapeutics Srl
 Anika Therapeutics Srl Chemicals: SpecialtyProcess Industries Provides hyaluronic acid-based products in several therapeutic areas including for the regeneration of connective and structural tissues damaged by injuries, aging or degenerative diseases | Corporate Officer/Principal | - |
Formation de Sylvia Cheung
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anika Therapeutics Srl
Anika Therapeutics Srl Chemicals: SpecialtyProcess Industries Provides hyaluronic acid-based products in several therapeutic areas including for the regeneration of connective and structural tissues damaged by injuries, aging or degenerative diseases | Process Industries |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
